(CRNO-B) Cereno Scientific - Performance 68% in 12m
Compare CRNO-B with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
50.59%
#11 in Group
Rel. Strength
93.75%
#501 in Universe
Total Return 12m
67.97%
#14 in Group
Total Return 5y
184.11%
#12 in Group
P/E -
(?) Percentile in Group
P/E Forward -
(?) Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield -10.22%
(?) Percentile in Group
12m Total Return: CRNO-B (68%) vs XBI (-12.1%)

5y Drawdown (Underwater) Chart

Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
ABBV NYSE AbbVie |
-19.2% | 9.47% | 151% | 75.1 | 14.6 | 0.38 | -49.6% | -19% |
UTHR NASDAQ United Therapeutics |
-11.7% | 23% | 168% | 11.8 | 10.6 | 1.43 | 83.8% | 78.5% |
HLN NYSE Haleon |
-1.45% | 26.1% | 39.7% | 24.7 | 20.3 | 1.8 | 27.1% | - |
AMGN NASDAQ Amgen |
-10.9% | 9.64% | 39.3% | 38.4 | 14.1 | 0.99 | -18.8% | -20% |
LONN SW Lonza |
-3.29% | 3.72% | 31.6% | 60.7 | 31.7 | 1.15 | 12.6% | -10.3% |
BIM PA Biomerieux |
2.96% | 17.6% | 11.9% | 31.5 | 25.4 | 1.47 | -58.7% | -25.1% |
NBIX NASDAQ Neurocrine Biosciences |
-10.2% | -24.7% | -1.51% | 29.1 | 20.7 | 0.27 | 61.5% | 31.6% |
KMDA NASDAQ Kamada |
-6.62% | 33.3% | -5.06% | 24.3 | 22.8 | 0.91 | 47.7% | 3.93% |
Performance Comparison: CRNO-B vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for CRNO-B
Total Return (including Dividends) | CRNO-B | XBI | S&P 500 |
---|---|---|---|
1 Month | 44.15% | -14.90% | -7.04% |
3 Months | 40.29% | -14.51% | -10.88% |
12 Months | 67.97% | -12.11% | 5.72% |
5 Years | 184.11% | -20.56% | 100.77% |
Trend Score (consistency of price movement) | CRNO-B | XBI | S&P 500 |
1 Month | 95.7% | -85.2% | -76.1% |
3 Months | 62.3% | -87.6% | -86.4% |
12 Months | 20.9% | -24% | 67.8% |
5 Years | 49.8% | -52.8% | 84.3% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
1 Month | #5 | 69.4% | 55.1% |
3 Month | #7 | 64.1% | 57.4% |
12 Month | #14 | 91.1% | 58.9% |
5 Years | #11 | 258% | 41.5% |
FAQs
Does CRNO-B Cereno Scientific outperforms the market?
Yes,
over the last 12 months CRNO-B made 67.97%, while its related Sector, the SPDR S&P Biotech (XBI) made -12.11%.
Over the last 3 months CRNO-B made 40.29%, while XBI made -14.51%.
Over the last 3 months CRNO-B made 40.29%, while XBI made -14.51%.
Performance Comparison CRNO-B vs Indeces and Sectors
CRNO-B vs. Indices CRNO-B is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | 26.6% | 51.2% | 28.3% | 62.3% |
US NASDAQ 100 | QQQ | 27.1% | 52.0% | 28.4% | 64.3% |
US Dow Jones Industrial 30 | DIA | 24.7% | 49.3% | 26.4% | 61.3% |
German DAX 40 | DAX | 14.1% | 52.2% | 9.76% | 48.7% |
Shanghai Shenzhen CSI 300 | CSI 300 | 19.6% | 51.9% | 23.5% | 60.0% |
Hongkong Hang Seng | HSI | 18.9% | 55.3% | 27.0% | 51.8% |
India NIFTY 50 | INDA | 22.6% | 40.7% | 28.9% | 67.3% |
Brasil Bovespa | EWZ | 22.1% | 50.4% | 28.0% | 78.9% |
CRNO-B vs. Sectors CRNO-B is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | 26.8% | 51.7% | 20.1% | 54.7% |
Consumer Discretionary | XLY | 28.2% | 50.4% | 26.1% | 60.6% |
Consumer Staples | XLP | 21.3% | 44.3% | 20.7% | 55.5% |
Energy | XLE | 25.6% | 56.1% | 29.4% | 80.8% |
Financial | XLF | 23.9% | 49.0% | 20.4% | 48.6% |
Health Care | XLV | 24.2% | 50.9% | 29.5% | 68.1% |
Industrial | XLI | 24.1% | 50.1% | 29.0% | 64.1% |
Materials | XLB | 23.1% | 51.6% | 35.8% | 75.9% |
Real Estate | XLRE | 20.8% | 49.1% | 28.6% | 53.6% |
Technology | XLK | 27.3% | 54.0% | 34.4% | 71.2% |
Utilities | XLU | 21.0% | 46.3% | 24.1% | 41.6% |
Aerospace & Defense | XAR | 21.9% | 44.8% | 18.9% | 44.8% |
Biotech | XBI | 22.0% | 59.1% | 44.2% | 80.1% |
Homebuilder | XHB | 27.2% | 53.4% | 47.8% | 79.7% |
Retail | XRT | 26.8% | 49.9% | 35.6% | 75.0% |